Abstract:Epidermal-growth-factor receptor[1] (EGFR) is a polypeptide with 1186 amino acids, which binds to EGF family growth factors. Two major natural ligands in the family interact with EGFR: one is EGF, the other is transforming growth factor-α (TGF-α)[2]. When EGF or TGF-α, binds to EGFR, tyrosine kinase activity is induced which in turn triggers a series of events regulating the cell growth[3-8]. The importance of EGFR in growth regulating pathways was confirmed by the fact that enhanced expression of this receptor was found in brain glioblastomas, breast, lung, ovarian, colorectal, and renal carcinomas[9,10]. Elevated EGFR levels correlated with poor prognosis in human tumors[11-17], for this reason, it seemed to be that EGFR would be a logical target for cancer therapy. Previous reports had shown that monoclonal antibodies to EGFR were effective in the treatment of many human carcinoma cells[18-20]. Other drug therapies which targeted the EGFR had also been successful. Kunkel had shown a drug that inhibited EGFR tyrosine kinase activity could inhibit the growth of A431 cells in nude mice[10]. Yoneda also reported that selective inhibitors of EGFR tyrosine kinase activity, such as tyrphostins, could inhibit the growth of squamous carcinoma in nude mice[21]. Antisense oligodeoxynucleotides inhibit gene expression on a highly selective and target sequence in a specific manner[22-25]. Specific oligonucleotides hybridize to complementary mRNA and decrease protein expression[26-29]. Antisense oligonucleotides against proto-oncogenes of growth factors had already been shown to be successful in cell lines[18,30]. For example, an antisense oligonucleotide to the erB2 gene product had been shown to inhibit protein production in a breast cancer cell line[31]. Akino reported inhibition of in vivo growth and metastases in malignant pituitary tumors with an antisense compound to the PTHrp (parathyroid hormone-related peptide)[32]. An oligonucleotide to the c-myc gene inhibited the growth of thyroid carcinoma cell lines[33]. Phosphorothioate antisense oligodeoxynucleotides targeted against human c-raf-1 kinase producing potent antiproliferative effects on cell culture and in vivo antitumor effects against a variety of tumor types[34]. The co-expression of EGFR along with TGF-α in human colon cancer cell lines, also in colon carcinoma tissue, had led to the suggestion that the autocrine stimulation of EGFR by its ligands could be a mechanism for tumor cells to escape from normal growth controls[35]. Previous studies in our laboratory confirmed over-expression of EGFR in HR8348 cells[36]. In this investigation, we hypothesized that growth and proliferation of HR8348 could be inhibited by EGFR ASODN. In this report 15-mer EGFR ASODN was synthesized and the effects of EGFR ASODN on cell proliferation and tumorigenic rate of HR8348 cells were observed.

Inhibition of Proliferation by Blockade of Epidermal Growth Factor Receptor in Human Prostate Carcinoma Cells

Blocking of the mitogen activated protein kinase signal transduction pathway inhibits the proliferation in the prostate cancer cells

Androgen and Epidermal Growth Factor Down-Regulate Cyclin-Dependent Kinase Inhibitor P27kip1 and Costimulate Proliferation of MDA PCa 2a and MDA PCa 2b Prostate Cancer Cells.

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Radiosensitivity of Prostate Cancer Cells is Enhanced by EGFR Inhibitor C225

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

[Regulation of EGF-receptor Expression by TGFalpha in Human Prostate Androgen-Unresponsive Cancer Cells].

Effects of Gefitinib and Small Interfering RNAs Targeting EGFRin the Treatment of Prostate Eallcer

Tyrphostin AG1478 Suppresses Proliferation and Invasion of Human Breast Cancer Cells

Regulation of ERRP-induced Inhibition of Proliferation in HCT-116 Colon Cancer Cell Line

The Action Mechanism Underlying the Effect of Epidermal Growth Factor Receptor Inhibitor Tyrphostin AG1478 on Human Breast Cancer Cells

17 β-estradiol inhibits cell proliferation via mitogen-activated protein kinase cascades in human prostate carcinoma cell line PC3

Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells

[Effects of RNA Interference Upon EGFR and Its Intracellular Effective Proteins in Prostate Cancer].

Inhibition of EGFR signaling in prostate cancer treated with EGFR siRNA and Gefitinib

[Epidermal Growth Factor Up-Regulates the Mrna Expression of Endothelin-1 and Its Receptors in Prostate Cancer PC-3 Cell Lines].

ShRNA-mediated silencing of the epidermal growth factor receptor gene inhibits proliferation of human HCT-15 colorectal cancer cells

Epidermal Growth Factor Receptor Inhibitor AG1478 Affects HepG2 Cell Proliferation, Cell Cycle, Apoptosis and C-Myc Protein Expression in a Dose-Dependent Manner

Effect of Withdrawal of Androgen on Expression of Cell Cycle Regulation Proteins in Human Prostate Carcinoma Cells

Inhibitory Effect of Resveratrol on EGFR-mediated Tumor

Inhibitory Effects of Egfr Antisense Oligodeoxynucleotide in Human Colorectal Cancer Cell Line